Navigation Links
Pharmaceutical Institute Acquires E-Learning Assets from GeneEd, Inc.
Date:12/17/2009

RALEIGH, N.C., Dec. 17 /PRNewswire/ -- Pharmaceutical Institute today announced that it has acquired e-learning assets from GeneEd, Inc., a company specializing in life science courseware. These assets, including 155 highly advanced e-courses, help expand Pharmaceutical Institute's already extensive library of training resources.

Pharmaceutical Institute is a leading provider of specialized training solutions for the pharmaceutical and biotech industry and a subsidiary of Campbell Alliance. Financial terms of the agreement were not disclosed.

"We are very pleased with the acquisition of these assets. GeneEd invested more than 10 years and $15 million in their creation, and the content they created is second to none," said John Campbell, CEO of Campbell Alliance. "Over 25 of the world's leading pharma and biotech companies are already using these materials with great success."

As part of the agreement, Pharmaceutical Institute acquired 155 e-courses, including:

  • 135 e-courses in key therapeutic areas, including cardiovascular, diabetes, respiratory, gastrointestinal, muscular skeletal, kidney, infection, oncology, central nervous system, pain and anesthesia, urinary, and metabolism.
  • 12 e-courses in biopharmaceutical technology, including human gene therapy, genomics, combinatorial chemistry, computer-assisted drug design, immunity and disease, bioinformatics, advanced bioinformatics, microarrays, SNPs, methods in microbiology, and microarray informatics.
  • 8 e-courses in clinical trial regulation, including biostatistics, adverse events reporting, good clinical practices, good laboratory practices, and 21 CFR part 11 (electronic records and signatures).

"Pharmaceutical Institute has focused its efforts on building an extensive library of e-course materials for the pharmaceutical and biotech industry. The resources we have acquired from GeneEd are comprehensive and highly technical in nature. This acquisition greatly increases the scope and scale of our distance learning catalog," said Garry O'Grady, Senior Vice President and General Manager of Pharmaceutical Institute.

The training resources acquired from GeneEd will add to Pharmaceutical Institute's already extensive library of training resources that include

  • Understanding Pharma - the most comprehensive introduction to the workings of the pharmaceutical and biotech industry and an end-to-end perspective on the functional areas of a typical biopharmaceutical company
  • Managed Markets Excellence - a comprehensive training solution that addresses the critical need for specialized training in the complex and constantly evolving managed markets environment for pharmaceutical and biologic products

About the Pharmaceutical Institute

Pharmaceutical Institute is a leading provider of specialized training programs for the pharmaceutical and biotech industry. We partner with subject matter experts from our parent company, Campbell Alliance, to develop highly-impactful distance learning solutions for professionals within all major pharmaceutical company functions, including Brand Management, Business Development, Clinical Development, Managed Markets, Medical Affairs, Sales, and Trade and Distribution. Pharmaceutical Institute is based in Raleigh, N.C. For more information, please visit www.pharmainstitute.com.

SOURCE Pharmaceutical Institute


'/>"/>
SOURCE Pharmaceutical Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Optimer Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference
2. Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma
3. KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent
4. Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
5. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
6. Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration
7. GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms
8. New Report Grades Sustainability Reporting of Top Pharmaceutical Companies
9. Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications
10. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
11. Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... July 10, 2017  US medical equipment and supply ... according to Medical Equipment & Supplies: United ... Focus Reports. Continued increases in demand for medical services ... the population and supported by gains in disposable personal ... supplies. New product introductions will also drive sales as ...
(Date:7/6/2017)... ThriveRx, the nutrition division of Diplomat Specialty Infusion Group, is ... nutrition support. To celebrate its anniversary, ThriveRx recently launched a ... new look with improved organization to create the best user experience for ... ... "We,ve made several great strides ...
(Date:7/1/2017)... 30, 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... conference call will be broadcast live over the Internet on ... news release detailing the quarterly results will be made available ... call. The live audio webcast can be accessed ... It will be archived for replay following the conference call. ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... 21, 2017 , ... The Visiting Nurse Association of ... R. Bard Foundation, Inc. to support the music therapy program offered at ... the nonprofit home care agency. Using evidence-based methods, professionally trained and certified music ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon Kleyne is ... product of her research center at Bio-Logic Aqua Research® Water Life Science®, has ... greatest number of sufferers of blindness. “We think that Nature’s Tears® EyeMist® will ...
(Date:7/21/2017)... ... July 21, 2017 , ... The most common ... improved quality of life five years after injury, according to research presented today ... Toronto, Ontario, Canada. The study followed patients for five years following surgery. , ...
(Date:7/20/2017)... ... , ... ChenMed , a leading provider of value-based care for seniors, ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family Medicine ... Ambulatory Services for the UVA Health System, brings 30 years of highly relevant experience ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... Houston, is pleased to announce their expansion to the Midwest with the establishment ... Alysse Hollis and Ronald Bell, and of counsels, John Peck and Robert Bruns, ...
Breaking Medicine News(10 mins):